{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(3)"],"submitter":["Fu L"],"pubmed_abstract":["<b><i>Background and Aims:</i></b> Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (commonly known as SARS-CoV-2) with multiple organ injuries. The aim of this study was to analyze COVID-19-associated liver dysfunction (LD), its association with the risk of death and prognosis after discharge. <b><i>Methods:</i></b> Three-hundred and fifty-five COVID-19 patients were recruited. Clinical data were collected from electronic medical records. LD was evaluated and its prognosis was tracked. The association between LD and the risk of death was analyzed. <b><i>Results:</i></b> Of the 355 COVID-19 patients, 211 had mild disease, 88 had severe disease, and 51 had critically ill disease. On admission, 223 (62.8%) p"],"journal":["Journal of clinical and translational hepatology"],"pagination":["246-254"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7562804"],"repository":["biostudies-literature"],"pubmed_title":["Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study."],"pmcid":["PMC7562804"],"pubmed_authors":["Li Y","Li MD","Liu FF","Xu S","Xiang Y","Fu L","Xu DX","Li XY","Fei J","Hu B","Xiang HX","Zhao H"],"additional_accession":[]},"is_claimable":false,"name":"Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.","description":"<b><i>Background and Aims:</i></b> Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (commonly known as SARS-CoV-2) with multiple organ injuries. The aim of this study was to analyze COVID-19-associated liver dysfunction (LD), its association with the risk of death and prognosis after discharge. <b><i>Methods:</i></b> Three-hundred and fifty-five COVID-19 patients were recruited. Clinical data were collected from electronic medical records. LD was evaluated and its prognosis was tracked. The association between LD and the risk of death was analyzed. <b><i>Results:</i></b> Of the 355 COVID-19 patients, 211 had mild disease, 88 had severe disease, and 51 had critically ill disease. On admission, 223 (62.8%) p","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Sep","modification":"2025-04-19T03:20:28.064Z","creation":"2020-10-29T12:37:22Z"},"accession":"S-EPMC7562804","cross_references":{"pubmed":["33083246"],"doi":["10.14218/JCTH.2020.00043"]}}